Elke Hauth1, Horst Jaeger2, Horst Hohmuth3, Meinrad Beer4. 1. Radiologische Praxis, Ulm, Germany. Electronic address: ehauth@t-online.de. 2. Radiologische Praxis, Ulm, Germany. Electronic address: horstjaeger@t-online.de. 3. Uropraxis, Ulm, Germany. Electronic address: hohmuth@uropraxis-ulm.de. 4. Department of Diagnostic and Interventional Radiology, University Hospital, Ulm, Germany. Electronic address: meinrad.beer@uniklinik-ulm.de.
Abstract
OBJECTIVE: To determine the rate of malignancy after follow-up MR imaging of the prostate in PI-RADS 3 lesions without core biopsy and PI-RADS 4 lesions after negative initial core biopsy. MATERIALS AND METHODS: We performed follow-up MRI in 46/72 (64%) patients with PI-RADS 3 lesions and 26/72 (36%) patients with PI-RADS 4 lesions in baseline MRI. RESULTS: The rate of malignancy in PI-RADS 3 lesions was 4% (2/46) and in PI-RADS 4 lesions 69% (18/26). CONCLUSIONS: Follow-up MRI for PI-RADS 3 lesions should be performed. For PI-RADS 4 lesions with initial negative biopsy we recommend an instant repeat core biopsy.
OBJECTIVE: To determine the rate of malignancy after follow-up MR imaging of the prostate in PI-RADS 3 lesions without core biopsy and PI-RADS 4 lesions after negative initial core biopsy. MATERIALS AND METHODS: We performed follow-up MRI in 46/72 (64%) patients with PI-RADS 3 lesions and 26/72 (36%) patients with PI-RADS 4 lesions in baseline MRI. RESULTS: The rate of malignancy in PI-RADS 3 lesions was 4% (2/46) and in PI-RADS 4 lesions 69% (18/26). CONCLUSIONS: Follow-up MRI for PI-RADS 3 lesions should be performed. For PI-RADS 4 lesions with initial negative biopsy we recommend an instant repeat core biopsy.
Authors: M Boschheidgen; L Schimmöller; S Doerfler; R Al-Monajjed; J Morawitz; F Ziayee; D Mally; M Quentin; C Arsov; P Albers; G Antoch; T Ullrich Journal: Sci Rep Date: 2022-04-25 Impact factor: 4.996
Authors: Ezequiel Becher; Shawn Karls; Angela Tong; James S Wysock; Samir S Taneja; William C Huang; Herbert Lepor Journal: World J Urol Date: 2022-10-05 Impact factor: 3.661